Therapeutic Antibodies – News and Features

News
New Alzheimer’s Therapies Provide Extra Months of Independence
An Alzheimer’s patient with very mild symptoms who undergoes treatment with one of the new, next-generation therapies could expect to gain eight or 10 months living independently, according to a study by researchers at WashU Medicine.

News
“All-Tablet” Treatment Shows Promise for Common Form of Leukemia
An international study of over 800 chronic lymphocytic leukemia (CLL) patients found that an all-tablet therapy of acalabrutinib-venetoclax – with or without obinutuzumab –improved progression-free survival compared to chemotherapy.

News
Cancer Vaccine Shows Promise for Advanced Kidney Cancer
A phase 1 trial of a personalized cancer vaccine for stage III/IV clear cell renal cell carcinoma showed promising results. The vaccine trained patients’ immune systems to target cancer cells, preventing recurrence.

Article
Five Years Later: Long COVID’s Lasting Impact on the Brain
Five years after SARS-CoV-2 first surfaced in Wuhan, China, researchers are still trying to understand long COVID. In this article, discover the latest research investigating the lasting impact of the virus on brain function.

News
Antibody Treatment Protects Monkeys Against Severe Bird Flu
A prophylactic antibody-based immune therapy has been shown to protect monkeys against severe bird flu caused by H1N1.

Article
How Broadly Neutralizing Antibodies Are Driving Next-Gen Vaccines
This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the prevention of HIV, but also for other rapidly mutating viruses such as influenza and SARS-CoV-2.

News
Potential Pancreatic Cancer Treatment Shows Promise
An antibody–drug conjugate could offer hope for pancreatic cancer treatment.

News
Off-the-Shelf Immunotherapy Approach Shows Promise for B-Cell Lymphoma
A new type of off-the-shelf cell-based immunotherapy shows promise for B-cell lymphomas, and could make make future cellular immunotherapies less expensive and more accessible.

News
Genetic Tweak Boosts Drug-Making Cells by Blocking Toxic Byproducts
Researchers have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, autoimmune diseases and much more.

News
Cancer Immunotherapy: How Therapeutic Antibodies Do Their Job
A new look at cancer cells: Würzburg researchers show how therapeutic antibodies work – thanks to an innovative method of super-resolution microscopy.
Advertisement